Compare uniQure N.V. Ordinary Shares (QURE) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Visa Inc — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while Visa Inc trades at $396.04 (market cap $743.55B). The key difference: Visa Inc is far larger — about 502.4× uniQure N.V. Ordinary Shares's market cap, and Visa Inc pays a 0.68% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Visa Inc for 115 Days on average.
| QURE | V | |
|---|---|---|
Market Cap | $1.48B | $743.55B |
Volume | 2,488,780 | 7,478,804 |
Sector | Health | Financials |
52-Week High | $70.59 | $396.06 |
52-Week Low | $9.03 | $295.52 |
Typical Hold Time | 0 Days | 115 Days |
Enterprise Value | $728.62M | $754.13B |
Dividend Yield | — | 0.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Visa (V) trades at $391.43, up 0.55% today, showing strong momentum near its resistance level of $392. The stock maintains bullish technical signals with consistent earnings beats in recent quarters and robust profitability metrics including 50.78% net margin and 61.79% ROE. Recent developments include the launch of Intelligent Commerce Connect for AI-powered commerce and expanded stablecoin partnerships, positioning Visa at the forefront of payment innovation.
Visa presents a compelling investment case with 85% analyst buy ratings and a $423.29 consensus price target representing 8% upside. Strong fundamentals are supported by $40B revenue and $20.1B net income for 2025, though elevated valuation ratios (P/E 33.71) and emerging fintech competition pose risks. The stock's outlook remains positive given its dominant market position and AI-driven growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
